Acomplia (Rimonabant) is a new miraculous multifunctional diet pill called "miracle pill".

According to a report published by the Journal of the American Medical Association, Acomplia produces sustained weight loss, helps to quit smoking, improves high-density lipoprotein (HDL) cholesterol and triglyceride levels and improves blood makers.

What is Acomplia?

• Acomplia (Rimonabant) is the new hope for overweight people and for people that have problems with their weight.
• Acomplia ( Rimonabant) is also known as SR141716, Riobant, Slimona, Rimoslim, and Zimulti.
• Acomplia was developed by Sanofi-aventis.

How does Acomplia work?

• Acomplia acts by selectively blocking CB1 receptors found in the brain and in peripheral organs important in glucose and lipid (or fat) metabolism, including adipose tissue, the liver, gastrointestinal tract and muscle.
• Acomplia (Rimonabant or Zimulti) diet pills offer hope for obese individuals. Especially where other treatments had little affect or whose side effects where too much to handle.
• Rimonabant Acomplia works by blocking the CB1 receptor, one of two receptors found in a newly described physiological system called the Endocannabinoid System (EC System) , believed to play a critical role in the regulation of food intake and energy expenditure. The receptors are present on the surfaces of many cells throughout the body, including fat cells — which are involved in lipid and glucose metabolism — and those in the hypothalamus, the brain region that is thought to determine appetite.

Does Acomplia also aid smoking cessation?

• Acomplia has been studied by sanofi-aventis as an aid to smoking cessation based on studies for up to one year in over 6,500 smokers motivated to quit smoking and the results were defined as Acomplia (Rimonabant) also aid smoking cessation.

What were the results of Generic Acomplia Clinical trial studies?

• In clinical studies, Acomplia has been shown to improve a wide array of cardiometabolic risk factors as well as promoting sustained weight loss4,5, but this depands on the patient because it works better with diet and exercises.
• Acomplia is a French drug designed to quit the smoking and check obesity. It suppresses the appetite by blocking hunger signals to brain. Acomplia affects endocannabinoid system. Acomplia targets newly discovered hunger center Cannabinoid receptors in the brain thus controlling the hunger..

What are the side-effects of Acomplia?

• Side effects in the trial on Acomplia in obesity were vomiting and nausea, forcing about 19 percent of patients to leave the trial versus 13 percent of those who took placebo. But for many others Acomplia helps.